Prevalence, Predictors, and Impact of Discontinuation of Clopidogrel Therapy after Drug-Eluting Stent Implantation
张强,马长生,聂绍平,吕强,康俊萍,杜昕,张崟,贾长琪,胡荣,刘新民,刘小慧,董建增,吴学思
DOI: https://doi.org/10.3969/j.issn.1004-8812.2009.03.007
2009-01-01
Abstract:Objective To evaluate the prevalence and the predictors of clopidogrel therapy after DES implantation,and to determine the impact of discontinuation of clopidogrel therapy on the occurrence of late stent thrombosis(ST)and very late stent thrombosis.Methods Between July 2003 and June 2005,2 930 consecutive patients treated with PCI and DES implantation in Anzhen hospital were involved in the study,and among them,13 patients died within 3 dys after PCI.A total of 2 704 patients out of the 2 917 patients were followed up successfully for at least 2 years,or mortality.All of the clinical,angiographic and intervention treatment character were recorded.ST was adjudicated by the definition of ARC Dublin.Patients were grouped by the duration of clopidogrel therapy to 4 groups(group 1,3 months;group 2,3-6 months;group 3,6-12 months;group 4,12 months).The duration of clopidogrel therapy and the predictors of the premature discontinuation of clopidogrel were evaluated,and the rate of late ST(1 month to 12 months)and very late ST(after 12 months)in the 4 groups were analysised.Results There were 82(3.0%)patients in group 1,333(12.3%)patients in group 2,1 590(58.8%)patients in group 3,and 699(25.9%)patients in group 4.In contrast with group 4,the mean level of total cholesterol were higher,mean LVEF value were lower,more patients were diabetes,less patients were STEMI,and the mean number of DES implantation was less in group 1-3.In group 1 and group 2,most of the discontinuation of clopidogrel therapy(95.1%,85.9% respectively)were directed by patients themselves;and in group 3,71.1% of the patients discortinued clopidogrel therapy on the doctor's order.There was no significant differences among the 3 groups on discontinuation of clopidogrel for bleeding or other operations.By Cox regression,diabetes(OR=1.542,95% CI=1.184-2.008,P=0.001)and number and DES implantation(OR=0.790,95% CI=0.709-0.880,P0.001)were found to be the independent predictors of discontinuation of clopidogrel.There were significant differences among the 4 groups on the rate of late ST and very late ST(6.1% vs 1.2% vs 0.8% vs 0%,P0.001).The late ST and very late ST rate of group 3 were also significantly higher than that of group 4(0.8% vs 0%,P=0.013).Conclusion In practice,approaching 75% of patients continue clopidogrel therapy no more than 12 months after DES implantation.Diabetes and number of DES implanted are the risk factors of prematurely discontinuation of clopidogrel therapy.The patients who premature discontinue clopidogrel therapy are prone to suffer from ST.